In this article, Roche discusses the increasing automation of science and next-generation sequencing (NGS) in particular and demonstrates an efficient DNA hybridization workflow.
/PRNewswire/ Rarecells, Inc. today announced the appointment of Dr. Neil Gunn, a recognized leader and expert in the diagnostic space, as an independent.
In this article, Roche Diagnostics elucidates upon some of their top tips and recommendations for anyone performing RNA-sequencing with degraded RNA inputs and demonstrate how to improve efficiency and performance.